XHKG
1936
Market cap242mUSD
Nov 02, Last price
4.18HKD
1D
2.70%
1Q
397.62%
IPO
41.69%
Name
Ritamix Global Ltd
Chart & performance
P/E
108.74
P/S
7.86
EPS
0.02
Vol. 1Y
110.13%
Shs. 5Y
0.53%
Rev. 5Y
2.06%
Div Yld LY
—
Div Yld TTM
7.13%
Revenues
128m
+4.70%
Net income
9m
+12.05%
CFO
14m
P
Dividend
Oct 21, 20260.29 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ritamix Global Limited functions as an investment holding company, primarily operating in Malaysia where it distributes a diverse range of animal feed additives and ingredients for human consumption. Its extensive product portfolio caters to various livestock, including poultry, swine, cattle, and aquaculture, encompassing items such as amino acids, vitamin premixes, acidifiers, enzymes, organic antioxidants, and other growth-enhancing components. Beyond its distribution efforts, the company also actively manufactures animal feed additive premixes. Ritamix further provides comprehensive services, offering expert guidance on feed nutrition, developing custom formulations, and delivering veterinary consultation along with technical support. Established in 1982 and based in Shah Alam, Malaysia, the company operates as a subsidiary of Garry-Worth Investment Limited.
Key people
Haw Yih Lee
Executive Chairman of the Board, Chief Executive Officer · since 2018
Sook Kean Yaw
Executive Director · since 2018
Foon Seng Choy
Business Development Manager
Jiun Ting Koh
Technical Executive
Poh Cheng Ting
Sales Manager
Po Lam Wong
Company Secretary · since 2021
Haw Shyang Lee
Non-Executive Director · since 2018
Siok Hui Ng
Independent Non-Executive Director · since 2020
Pao Hwei Tee
Non-Executive Independent Director · since 2024
Valuation
Title MYR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||